ATE18562T1 - Zellspezifische glykopeptidliganden. - Google Patents
Zellspezifische glykopeptidliganden.Info
- Publication number
- ATE18562T1 ATE18562T1 AT82103247T AT82103247T ATE18562T1 AT E18562 T1 ATE18562 T1 AT E18562T1 AT 82103247 T AT82103247 T AT 82103247T AT 82103247 T AT82103247 T AT 82103247T AT E18562 T1 ATE18562 T1 AT E18562T1
- Authority
- AT
- Austria
- Prior art keywords
- cell
- mannopyranosylthio
- metabolizable
- propionyl
- lysine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/255,416 US4386026A (en) | 1981-04-20 | 1981-04-20 | Cell-specific glycopeptide ligands |
EP82103247A EP0063373B1 (de) | 1981-04-20 | 1982-04-19 | Zellspezifische Glykopeptidliganden |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE18562T1 true ATE18562T1 (de) | 1986-03-15 |
Family
ID=22968229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT82103247T ATE18562T1 (de) | 1981-04-20 | 1982-04-19 | Zellspezifische glykopeptidliganden. |
Country Status (10)
Country | Link |
---|---|
US (1) | US4386026A (de) |
EP (1) | EP0063373B1 (de) |
JP (1) | JPS57181095A (de) |
AT (1) | ATE18562T1 (de) |
DE (1) | DE3269778D1 (de) |
DK (1) | DK173282A (de) |
ES (1) | ES8306162A1 (de) |
GR (1) | GR76475B (de) |
IE (1) | IE52473B1 (de) |
PT (1) | PT74747B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4701521A (en) * | 1978-07-17 | 1987-10-20 | The Trustees Of Boston University | Method of effecting cellular uptake of molecules |
US4466951A (en) * | 1982-11-12 | 1984-08-21 | University Of California | Intracellular trapping of therapeutics or tracer agents |
FR2551442B1 (fr) * | 1983-09-05 | 1987-04-30 | Centre Nat Rech Scient | Nouveaux derives furaniques, leur preparation et leur application |
US4873322A (en) * | 1986-01-24 | 1989-10-10 | Ciba-Geigy Corporation | Saccharide derivatives and processes for their manufacture |
US4946675A (en) * | 1987-05-27 | 1990-08-07 | Xoma Corporation | Hepatic blocking agents |
US5879680A (en) * | 1987-12-23 | 1999-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | Cloned DNA for synthesizing unique glucocerebrosidase |
ZA9010460B (en) * | 1989-12-29 | 1992-11-25 | Univ Technologies Int | Methods for modelling tertiary structures of biologically active ligands including agonists and antagonists thereto and novel synthetic antagonists based on angiotensin |
US5432260A (en) * | 1991-05-03 | 1995-07-11 | Washington University | High affinity mannose receptor ligands |
US5332575A (en) * | 1991-10-03 | 1994-07-26 | Parfums Christian Dior | Method of targeting melanocytes with a compound containing a fucose residue |
EP0647133A4 (de) * | 1992-06-12 | 1997-10-29 | Affymax Tech Nv | Zusammensetzungen und verfahren zur verbesserte arzneimittelabgabe. |
TW263437B (de) * | 1992-09-24 | 1995-11-21 | Takeda Pharm Industry Co Ltd | |
US5508387A (en) * | 1993-08-04 | 1996-04-16 | Glycomed Incorporated | Selectin binding glycopeptides |
CA2173990A1 (en) * | 1993-10-12 | 1995-04-20 | Narasinga Rao | A library of glyco-peptides useful for identification of cell adhesion inhibitors |
JP4256932B2 (ja) * | 1995-06-07 | 2009-04-22 | ジョエル ケイ. スワデッシュ | 抗原プロセシング細胞標的複合体 |
US5965719A (en) * | 1996-11-15 | 1999-10-12 | Sunsorb Biotech, Inc. | Combinatorial synthesis of carbohydrate libraries |
WO1998031392A1 (fr) * | 1997-01-17 | 1998-07-23 | Drug Delivery System Institute, Ltd. | Medicaments nephrotropiques |
NZ337924A (en) * | 1997-02-20 | 2002-09-27 | Klaus Kimmeldirk | Site-specific drug delivery compounds comprising an anchoring moiety, a linking group and a drug |
US7033765B1 (en) | 1997-02-20 | 2006-04-25 | Toronto Research Chemicals, Inc. | Site-specific drug delivery |
ES2265162T3 (es) * | 1997-03-27 | 2007-02-01 | Institut Pasteur | Carbohidrato glucopeptido de antigeno multiple, vacuna que comprende el mismo y su utilizacion. |
CA2299295C (en) * | 1997-08-08 | 2010-11-30 | Aventis Pharma Deutschland Gmbh | Substituted tetrahydropyrane derivatives and method for producing same |
CA2348931A1 (en) * | 1998-10-30 | 2000-05-11 | Daiichi Pharmaceutical Co., Ltd. | Dds compound and method for measurement thereof |
US6656498B1 (en) * | 1998-11-25 | 2003-12-02 | Vanderbilt University | Cationic liposomes for gene transfer |
WO2002010219A1 (en) * | 2000-07-26 | 2002-02-07 | Cho, Sung-Woo | Oligolysine transducing domain, oligolysine-cargo molecule complex and uses thereof |
WO2003051113A1 (en) | 2001-12-14 | 2003-06-26 | The University Of Wyoming | Methods and compositions for controlled release of drugs |
CN103804458B (zh) * | 2014-02-25 | 2016-08-24 | 中国人民解放军第四军医大学 | 基于胆固醇的三种脂质材料的制备及其应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3226379A (en) * | 1964-01-14 | 1965-12-28 | Grace W R & Co | Novel 1,3-bis(polyhydroxyalkyl)-2-imidazolidinones and 1,3-bis(polyhydroxyalkyl)-imidazolidine-2-thiones |
US3859337A (en) * | 1969-06-11 | 1975-01-07 | Stauffer Chemical Co | Ethylenediaminetetraacetic acid anhydride derivatives |
US3953594A (en) * | 1971-08-13 | 1976-04-27 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Process for preparing bleomycin group antibiotics |
IT1050366B (it) * | 1972-10-18 | 1981-03-10 | Chinos Ind Farmacobilologica S | Sali di amminoacidi con esteri polisolforici di glicopeptidi naturali e loro preparazione |
US4195128A (en) * | 1976-05-03 | 1980-03-25 | Bayer Aktiengesellschaft | Polymeric carrier bound ligands |
SE431758B (sv) * | 1977-03-04 | 1984-02-27 | Pharmacia Fine Chemicals Ab | Som tioleringsreagens eller berarmatris for enzymer anvendbart derivat av en sh-grupphaltig polymer |
US4120953A (en) * | 1977-04-04 | 1978-10-17 | American Cyanamid Company | Novel 2,2', 2"-[s-phenenyltris(sulfonylimino)tris]-[2-deoxy-α-D-glucopyranose], dodecakis (H-sulfate) compounds and their salts |
US4241053A (en) * | 1978-08-25 | 1980-12-23 | Tanabe Seiyaku Co., Ltd. | Novel nitrosourea compounds and process for preparing the same |
US4223013A (en) * | 1978-12-29 | 1980-09-16 | Syva Company | Amitriptyline conjugates to antigenic proteins and enzymes |
US4267102A (en) * | 1979-03-05 | 1981-05-12 | Nippon Kayaku Kabushiki Kaisha | Bleomycin group antibiotics |
JPS5646897A (en) * | 1979-09-26 | 1981-04-28 | Seiichi Shibata | Novel glycopeptide |
US4259233A (en) * | 1979-10-23 | 1981-03-31 | Miles Laboratories, Inc. | β-Galactosyl-umbelliferone-labeled protein and polypeptide conjugates |
CA1203532A (en) * | 1980-07-10 | 1986-04-22 | Chembiomed Ltd. | Synthesis of tumor antigenic determinant |
-
1981
- 1981-04-20 US US06/255,416 patent/US4386026A/en not_active Expired - Fee Related
-
1982
- 1982-04-13 GR GR67908A patent/GR76475B/el unknown
- 1982-04-14 PT PT74747A patent/PT74747B/pt not_active IP Right Cessation
- 1982-04-16 IE IE898/82A patent/IE52473B1/en not_active IP Right Cessation
- 1982-04-19 DE DE8282103247T patent/DE3269778D1/de not_active Expired
- 1982-04-19 ES ES511516A patent/ES8306162A1/es not_active Expired
- 1982-04-19 DK DK173282A patent/DK173282A/da active IP Right Grant
- 1982-04-19 EP EP82103247A patent/EP0063373B1/de not_active Expired
- 1982-04-19 AT AT82103247T patent/ATE18562T1/de not_active IP Right Cessation
- 1982-04-20 JP JP57064870A patent/JPS57181095A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PT74747B (en) | 1985-01-08 |
ES511516A0 (es) | 1983-05-01 |
PT74747A (en) | 1982-05-01 |
GR76475B (de) | 1984-08-10 |
IE52473B1 (en) | 1987-11-11 |
DE3269778D1 (en) | 1986-04-17 |
JPS57181095A (en) | 1982-11-08 |
ES8306162A1 (es) | 1983-05-01 |
US4386026A (en) | 1983-05-31 |
IE820898L (en) | 1982-10-20 |
EP0063373A1 (de) | 1982-10-27 |
EP0063373B1 (de) | 1986-03-12 |
DK173282A (da) | 1982-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE18562T1 (de) | Zellspezifische glykopeptidliganden. | |
Kapas et al. | Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor-alpha and TNF-alpha fragments | |
US5597578A (en) | TGF-β protein compositions for inhibition of cell proliferation | |
AU655187B2 (en) | Continuous release pharmaceutical compositions | |
WO1999024074A3 (en) | Novel conjugates of opioids and endogenous carriers | |
HUP0101545A1 (hu) | Peptideket időben elnyújtva kibocsátó gyógyászati készítmények és eljárás az előállításukra | |
AU7479796A (en) | Preparation of peptide containing biodegradable microspheres by melt process | |
YU48102B (sh) | Postupak za izradu flastera sa aktivnom materijom koji sadrži estrogen | |
KR20040043113A (ko) | 당뇨병의 치료방법 | |
Poznansky et al. | Insulin: carrier potential for enzyme and drug therapy | |
KR890000520A (ko) | 폴리펩티드 | |
JPS57140725A (en) | Physiologically active substance having carcinostatic action | |
Melton et al. | Covalent linkage of carboxypeptidase G2 to soluble dextrans—II: in vivo distribution and fate of conjugates | |
JPH0347114A (ja) | 直腸及び膣適用に適する、生物学的に活性なペプチド薬剤を製造する方法 | |
Lin et al. | Granule proteins of the dental follicle and stellate reticulum inhibit tooth eruption and eyelid opening in postnatal rats | |
Sahba et al. | Synthetic and secretory effects of cholecystokinin-pancreozymin on the pigeon pancreas | |
CA2006106A1 (en) | Improved phase separation-microencapsulated pharmaceutical compositions useful for alleviating dental disease | |
Rawale et al. | Synthesis and biological activity of the prodrug of class I major histocompatibility peptide GILGFVFTL activated by β-glucuronidase | |
JPH06293631A (ja) | ケラチン加水分解物を担体として用いたドラッグデリバリーシステム | |
SU651812A1 (ru) | Способ предупреждени образовани спаек | |
Yamashita et al. | Autoradiographic study of tissue distribution of [3H] ubenimex in IMC carcinoma-bearing mice | |
RU2188032C1 (ru) | Средство, стимулирующее дифференцировку т-лимфоцитов | |
Thornton et al. | Incorporation of [3H] phenylalanine into corticotrophin by the posterior pituitary of the mouse in vitro | |
STRATFORD | PERMEATION AND METABOLIC BARRIERS TO THE ABSORPTION AND DISTRIBUTION OF TOPICALLY APPLIED ENKEPHALINS IN THE ALBINO RABBIT EYE. | |
Janecka et al. | Hypotensive activity of histidine-containing analogues of C-terminal hexapeptide of Substance P |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |